Bruce Levine, CAR-T therapies, Carl June, Gilead, Kite, Tmunity Therapeutic, University of Pennsylvania
Kite completes acquisition of Tmunity
Press Release Feb 2023: - Kite, a Gilead Company (NASDAQ: GILD), today announced the completion of the previously announced transaction to acquire Tmunity Therapeutics (Tmunity), a clinical-stage, private biotech compan..
CAR-T therapies, chimeric antigen receptors, China, ciltacabtagene autoleucel, Janssen Biotech, Legend biotech
CARVYKTI (ciltacabtagene autoleucel), BCMA-Directed CAR-T Therapy, receives U.S. FDA approval for the treatment of adult patients with relapsed or refractory multiple myeloma
March 2022: According to Johnson & Johnson, a therapy developed by the company and its China-based partner Legend Biotech Corp to treat a kind of white blood cell cancer has been approved by the US Food and Drug Administrati..